Here are what the editors at HealthDay consider to be the most important developments in Nephrology for September 2016. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
CDC: Too Many Health Care Workers Not Getting Flu Vaccine
FRIDAY, Sept. 30, 2016 (HealthDay News) -- Roughly one in every five American health care workers do not receive the annual influenza vaccination, and in some facilities that number exceeds half, according to research published in the Sept. 30 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Full Text
Meditation Recommended for Helping Attendings 'Attend'
FRIDAY, Sept. 30, 2016 (HealthDay News) -- Meditation can allow attending physicians to be "in attendance" in order to heal and maintain personal well-being, according to an article published by the American Medical Association.
More Information
Capping Copays Will Raise Premiums, Up Drug Prices
THURSDAY, Sept. 29, 2016 (HealthDay News) -- The proposed capping of copays will raise premiums and is likely to increase drug prices, according to a report from the National Center for Policy Analysis (NCPA).
More Information
Constitutional Symptoms Often Trigger Antibiotic Rx in Elderly
THURSDAY, Sept. 29, 2016 (HealthDay News) -- Constitutional symptoms, including mentation, often lead to diagnostic testing and potentially inappropriate antibiotic prescribing in older patients suspected of having a urinary tract infection (UTI) or pneumonia, according to a study published online Sept. 22 in the Journal of the American Geriatrics Society.
Abstract
Full Text (subscription or payment may be required)
Considerable Number of Doctors Attend Patient Funerals
THURSDAY, Sept. 29, 2016 (HealthDay News) -- A considerable proportion of doctors attend patient funerals, including 71 percent of general practitioners (GPs), according to a study published online Sept. 9 in Death Studies.
Full Text (subscription or payment may be required)
Systolic Blood Pressure Variability Linked to Mortality, Morbidity
THURSDAY, Sept. 29, 2016 (HealthDay News) -- Systolic blood pressure variability (SBPV) is associated with mortality, coronary heart disease (CHD), stroke, and end-stage renal disease (ESRD), according to a study published in the Sept. 27 issue of the Journal of the American College of Cardiology.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Many Doctors Reluctant to Reveal Mental Health Issues
WEDNESDAY, Sept. 28, 2016 (HealthDay News) -- Wary of the stigma of a mental health diagnosis and its toll on their careers, physicians often avoid getting help for depression and other mental illnesses, according to a report published online Sept. 15 in General Hospital Psychiatry.
Full Text (subscription or payment may be required)
AMA: Practicing Empathy May Lead to More Joy in Medicine
MONDAY, Sept. 26, 2016 (HealthDay News) -- Empathetic listening can help physicians navigate difficult situations and forge deeper connections with patients, leading to greater professional satisfaction and joy, according to the American Medical Association.
More Information
Anxiety Disorders Important in ESRD Treated With Hemodialysis
MONDAY, Sept. 26, 2016 (HealthDay News) -- Anxiety disorders are an important clinical problem in patients with end-stage renal disease (ESRD) treated with hemodialysis (HD), according to a review published online Sept. 22 in the Clinical Journal of the American Society of Nephrology.
Abstract
Full Text (subscription or payment may be required)
Most U.S. CKD Patients Receive Renal Replacement Therapy
FRIDAY, Sept. 23, 2016 (HealthDay News) -- Most U.S. patients with advanced chronic kidney disease receive renal replacement therapy (RRT), according to a study published online Sept. 22 in the Clinical Journal of the American Society of Nephrology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Decline in eGFR Mainly Linear in Type 1 Diabetes
THURSDAY, Sept. 22, 2016 (HealthDay News) -- For patients with type 1 diabetes, the decline of estimated glomerular filtration rate (eGFR) is mainly linear, according to a study published online Sept. 19 in Diabetes Care.
Full Text (subscription or payment may be required)
Research Reveals 2 Genetic Loci Linked to Acute Kidney Injury
WEDNESDAY, Sept. 21, 2016 (HealthDay News) -- Four single-nucleotide polymorphisms at two loci that are associated with acute kidney injury have been identified, according to a study published online Aug. 30 in the American Journal of Respiratory and Critical Care Medicine.
Full Text (subscription or payment may be required)
Hospitals Increasingly Employing Doctors, Effects on Care Uncertain
TUESDAY, Sept. 20, 2016 (HealthDay News) -- Hospitals are increasingly switching to an employment relationship with physicians, but switching has had no impact on primary composite quality metrics, according to a study published online Sept. 20 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Average Premiums for Health Care Coverage Stable in 2016
MONDAY, Sept. 19, 2016 (HealthDay News) -- The average annual premiums for single and family coverage remained stable in 2016, according to a study published online Sept. 14 in Health Affairs.
Abstract
Full Text
Early Rx With Losartan Doesn't Slow Kidney Disease Progression
FRIDAY, Sept. 16, 2016 (HealthDay News) -- For American-Indians with type 2 diabetes, early administration of losartan does not slow progression of glomerular filtration rate (GFR) decline, according to a study published online Sept. 9 in Diabetes Care.
Full Text (subscription or payment may be required)
Importance of Drug As Assessed by Doctor Not Tied to Adherence
THURSDAY, Sept. 15, 2016 (HealthDay News) -- Physician-assessed drug importance is not associated with patient-reported drug adherence, according to a study published in the September/October issue of the Annals of Family Medicine.
Abstract
Full Text
Recommendations Developed for Cost-Effectiveness Analyses
THURSDAY, Sept. 15, 2016 (HealthDay News) -- A new set of recommendations has been developed for conduct and reporting of cost-effectiveness analyses, according to a report published in the Sept. 13 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Value-Driven Outcomes Tool Can Cut Health Care Costs
WEDNESDAY, Sept. 14, 2016 (HealthDay News) -- A multifaceted value-driven outcomes tool that identifies variability in costs and outcomes can reduce health care costs, according to a study published in the Sept. 13 issue of the Journal of the American Medical Association.
Abstract
Full Text
Editorial (subscription or payment may be required)
Many Medicare Patients Non-Adherent to Antihypertensives
WEDNESDAY, Sept. 14, 2016 (HealthDay News) -- Nearly five million Medicare prescription drug enrollees aren't taking their antihypertensive medication as directed, according to research published in the Sept. 13 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Full Text
New Anticancer Drugs Up Costs and Life Expectancy Considerably
TUESDAY, Sept. 13, 2016 (HealthDay News) -- New anticancer drugs, which increase costs considerably, are associated with large gains in life expectancy, according to research published in the September issue of Health Affairs.
Abstract
Full Text (subscription or payment may be required)
Advanced Glycation End Products Tied to Renal Function Loss
TUESDAY, Sept. 13, 2016 (HealthDay News) -- For American-Indians with type 2 diabetes, advanced glycation end products (AGEs) are associated with renal function loss (RFL), according to a study published online Sept. 8 in Diabetes.
Full Text (subscription or payment may be required)
Liraglutide, Sitagliptin Have No Effect on Renal Hemodynamics
FRIDAY, Sept. 9, 2016 (HealthDay News) -- In insulin-naive patients with type 2 diabetes, 12 weeks of treatment with liraglutide or sitagliptin has no effect on renal hemodynamics, according to a study published online Sept. 1 in Diabetes Care.
Full Text (subscription or payment may be required)
Limited Dialyzability for Oxycodone, Noroxycodone
THURSDAY, Sept. 8, 2016 (HealthDay News) -- For patients with chronic pain with end-stage renal disease, oxycodone and noroxycodone have limited dialyzability, according to a study published online Sept. 2 in Pain Practice.
Abstract
Full Text (subscription or payment may be required)
Obesity May Up Survival in Metastatic Renal Cell Carcinoma
THURSDAY, Sept. 8, 2016 (HealthDay News) -- Obesity may increase survival for patients with metastatic renal cell carcinoma (RCC), according to a study published online Sept. 6 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Donor, Recipient Characteristics Impact Transplant Costs
THURSDAY, Sept. 1, 2016 (HealthDay News) -- Kidney donor and recipient characteristics impact transplant costs, according to a study published online Aug. 27 in the American Journal of Transplantation.
Abstract
Full Text (subscription or payment may be required)
